IP Library Granted Patent US 8,672,924
Granted Patent B2
US 8,672,924 · App. 13/691,691 · Granted Mar 18, 2014

System and method for determining dosimetry in ophthalmic photomedicine

Inventors: Daniel V. Palanker (Sunnyvale, CA); Dan Andersen (Menlo Park, CA)
Assignee: Topcon Medical Laser Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,672,924
App. No.
13/691,691
Granted
Mar 18, 2014
Kind
B2
Abstract

A system and method for treating ophthalmic target tissue, including a light source for generating a beam of light, a beam delivery system that includes a scanner for generating patterns, and a controller for controlling the light source and delivery system to create a dosimetry pattern of the light beam on the ophthalmic target tissue. One or more dosage parameters of the light beam vary within the dosimetry pattern, to create varying exposures on the target tissue. A visualization device observes lesions formed on the ophthalmic target tissue by the dosimetry pattern. The controller selects dosage parameters for the treatment beam based upon the lesions resulting from the dosimetry pattern, either automatically or in response to user input, so that a desired clinical effect is achieved by selecting the character of the lesions as determined by the dosimetry pattern lesions.

Claims (28)

1. A method of treating ophthalmic target tissue using a treatment pattern of lesions, wherein the treatment pattern comprises a first sub-pattern of lesions and a second sub-pattern of lesions, the method comprising:

delivering a beam of light to the ophthalmic target tissue;

creating, using the delivered beam of light, the first sub-pattern of lesions on the ophthalmic target tissue, wherein the first sub-pattern includes:

a plurality of ophthalmoscopically invisible lesions, and

at least one ophthalmoscopically visible lesion;

after creating the first sub-pattern, aligning the beam of light based on an ophthalmoscopically visible lesion from the first sub-pattern, and creating the second sub-pattern of lesions on the ophthalmic target tissue using the aligned beam of light,

wherein the ophthalmoscopically visible lesion from the first sub-pattern indicates an end of the first sub-pattern, and

wherein the second sub-pattern is adjacent the first sub-pattern but does not overlap the first sub-pattern.

2. The method of claim 1 , wherein:

the first sub-pattern of lesions includes at least two ophthalmoscopically visible lesions.

3. The method of claim 1 , wherein:

the first sub-pattern includes a first row of lesions.

4. The method of claim 3 , wherein:

the ophthalmoscopically visible lesion from the first sub-pattern that indicates an end of the first sub-pattern is the first lesion in the first row of lesions.

5. The method of claim 4 , wherein:

the first sub-pattern includes a second row of lesions aligned below the first row of lesions.

6. The method of claim 5 , wherein:

the lesions in the first row and second row are non-abutting and non-overlapping.

7. The method of claim 1 , wherein:

the plurality of ophthalmoscopically invisible lesions are formed using a shorter pulse duration of the beam of light than the at least one ophthalmoscopically visible lesion.

8. The method of claim 1 , wherein:

the plurality of ophthalmoscopically invisible lesions are formed using a lower power density of the beam of light than the at least one ophthalmoscopically visible lesion.

9. The method of claim 1 , wherein:

the plurality of ophthalmoscopically invisible lesions are formed using a shorter pulse duration and a lower power density of the beam of light than the at least one ophthalmoscopically visible lesion.

10. The method of claim 1 ,

wherein the first sub-pattern includes at least two rows of lesions,

wherein a first row of the at least two rows of lesions is aligned above a second row of the at least two rows of lesions,

wherein the ophthalmoscopically visible lesion from the first sub-pattern that indicates an end of the first sub-pattern is at one end of the second row of lesions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: TOPCON MEDICAL LASER SYSTEMS, INC.
To: IRIDEX CORPORATION
Reel/Frame 056836/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2013
From: PALANKER, DANIEL V.; ANDERSEN, DAN
To: TOPCON MEDICAL LASER SYSTEMS, INC.
Reel/Frame 029715/0733 →
Continuity (3)
Continuation 11939398 · Nov 13, 2007
Provisional Application 60857951 · Nov 10, 2006
Related Publication 20130096543A1 · Apr 18, 2013